Apoptin, a chicken anemia virus-derived protein, induces apoptosis in various tumor cell lines and xenografted tumors. Its apoptotic activity is not hampered by tumor-suppressor p53 mutations or overexpression of anti-apoptosis proteins Bcl-2 or Bcl-xL. We report for the first time the effects of apoptin expression in primary oral tumors, induced by the carcinogen 4-Nitroquinoline- 1-oxide in immunocompetent mice. In vivo a significant amount of primary oral tumor cells expressing apoptin cells underwent apoptosis, whereas synthesis of the LacZ control product did not. Ectopical expression of apoptin in passage 1 cell cultures derived from these oral tumors also resulted in apoptin-induced. Both in-vivo and in-vitro treated cells underwent apoptosis via the activation of caspase-3. The fact that apoptin induces apoptosis in primary squamous cell carcinoma cells indicates that apoptin is a potential therapeutic agent for treatment of head and neck squamous cell carcinoma.

, , , , , ,
doi.org/10.4161/cbt.7.9.6419, hdl.handle.net/1765/75045
Cancer Biology and Therapy
Department of Otorhinolaryngology

Schoop, R., Baatenburg de Jong, R. J., & Noteborn, M. (2008). Apoptin induces apoptosis in an oral cancer mouse model. Cancer Biology and Therapy, 7(9), 1368–1373. doi:10.4161/cbt.7.9.6419